Suppr超能文献

变应性鼻炎的基层医疗管理:一项在四个东盟国家开展的横断面研究。

Primary care management of allergic rhinitis: a cross-sectional study in four ASEAN countries.

作者信息

Abdullah Baharudin, Snidvongs Kornkiat, Recto Marysia, Poerbonegoro Niken Lestari, Wang De Yun

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.

Endoscopic Nasal and Sinus Surgery Excellence Center Chulalongkorn Hospital, Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University, Thailand.

出版信息

Multidiscip Respir Med. 2020 Dec 11;15(1):726. doi: 10.4081/mrm.2020.726. eCollection 2020 Jan 28.

Abstract

BACKGROUND

In primary care, general practitioners (GPs) and pharmacists are tasked with the frontline responsibility of identifying and managing allergic rhinitis (AR) patients. There are currently no consolidated data on current treatment practices, patient compliance, and usage of guidelines within Southeast Asian Nations (ASEAN). Objective: To assess the attitudes and practices on AR of GPs and pharmacists in 4 ASEAN countries (Philippines, Indonesia, Thailand, and Malaysia).

METHODS

A cross-sectional survey of 329 GPs and 548 pharmacists was conducted from May to November 2019. Participants answered a questionnaire focused on their i) current practice in the management of AR, ii) views on patient compliance, iii) understanding and usage of guidelines.

RESULTS

Clinical history was the most preferred method to diagnose AR by 95.4% of GPs and 58.8% of pharmacists. Second-generation antihistamines were the most widely available treatment option in GP clinics and pharmacies (94.8% and 97.2%) and correspondingly the most preferred treatment for both mild (90.3%, 76.8%) to moderatesevere rhinitis (90.3%, 78.6%) by GPs and pharmacists, respectively. Loratadine was ranked as the most preferred 2 generation antihistamines (GP vs pharmacists: 55.3% vs 58.9%). More than 90% of GPs and pharmacists ranked length and efficacy of treatment as important factors that increase patient compliance. Awareness of the ARIA guidelines was high among GPs (80%) and lower among pharmacists (48.4%). However, only 63.3% of GPs and 48.2% of pharmacists knew how to identify AR patients.

CONCLUSIONS

The survey in the 4 ASEAN countries has identified a need to strengthen the awareness and use of ARIA guidelines among the primary care practitioners. Adherence to ARIA guidelines, choosing the appropriate treatment option and prioritizing factors that increases patient compliance may contribute to better management outcomes of AR at the primary care practice.

摘要

背景

在初级医疗保健中,全科医生(GP)和药剂师肩负着识别和管理过敏性鼻炎(AR)患者的一线责任。目前东南亚国家联盟(东盟)内关于当前治疗实践、患者依从性和指南使用情况尚无综合数据。目的:评估4个东盟国家(菲律宾、印度尼西亚、泰国和马来西亚)的全科医生和药剂师对AR的态度和实践。

方法

2019年5月至11月对329名全科医生和548名药剂师进行了横断面调查。参与者回答了一份问卷,重点关注他们:i)目前AR管理的实践;ii)对患者依从性的看法;iii)对指南的理解和使用情况。

结果

95.4%的全科医生和58.8%的药剂师将临床病史作为诊断AR的最常用方法。第二代抗组胺药是全科医生诊所和药店中最普遍可用的治疗选择(分别为94.8%和97.2%),相应地也是全科医生和药剂师对轻度(分别为90.3%、76.8%)至中重度鼻炎(分别为90.3%、78.6%)最常用的治疗方法。氯雷他定被列为最常用的第二代抗组胺药(全科医生与药剂师:55.3%对58.9%)。超过90%的全科医生和药剂师将治疗时长和疗效列为提高患者依从性的重要因素。全科医生对ARIA指南的知晓率较高(80%),药剂师的知晓率较低(48.4%)。然而,只有63.3%的全科医生和48.2%的药剂师知道如何识别AR患者。

结论

在4个东盟国家进行的调查表明,有必要加强初级医疗保健从业者对ARIA指南的认识和使用。遵守ARIA指南、选择合适的治疗方案以及优先考虑提高患者依从性的因素,可能有助于在初级医疗保健实践中更好地管理AR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d8/7750812/5443cb96b0a7/mrm-15-1-726-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验